HSP90AA1 is highly expressed in a variety of malignancies, including breast, endometrial, ovarian, colon, lung, and prostate cancers (Kang et al., 2010; Y; Li et al., 2011; Soroka et al., 2012), which is consistent with our conclusion based on the TCGA database. Here, HSP90AA1 is linked to prostate cancer.